Clinical trial
Investigation of Systemic Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of Coronavirus Disease-19.
NCT04406545 is registered in ClinicalTrials.gov with National Institute of Cardiology, Laranjeiras, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Systemic Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of Coronavirus Disease-19.
- Lead sponsor
- National Institute of Cardiology, Laranjeiras, Brazil
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 15, 2020
- Completion date
- January 10, 2022
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection, endothelial dysfunction, microvascular rarefaction